MyFinsight
Home
Blog
About
cost of sales
(exclusive of depreciation...
$270,862K
cost of sales
(exclusive of depreciation...
$243,537K
adjusted ebitda-pharma
segment-Pharma Segment
$153,905K
cost of sales
(exclusive of depreciation...
$146,864K
selling, research&
development and...
$65,145K
selling, research&
development and...
$52,846K
adjusted ebitda-beauty
segment-Beauty Segment
$44,742K
adjusted
ebitda-closures...
$29,849K
selling, research&
development and...
$24,707K
Net sales
$1,026,508K
(6.26%↑ Y/Y)
other segment
items-pharma segment-Pharma...
-$4,420K
other segment
items-beauty segment-Beauty...
-$996K
other segment
items-closures...
-$533K
Operating income
$126,722K
(-12.24%↓ Y/Y)
Total operating
expenses
$899,786K
(9.51%↑ Y/Y)
Income before income
taxes
$115,047K
(-17.66%↓ Y/Y)
Total other (expense)
income
-$11,675K
(-149.52%↓ Y/Y)
Interest income
$2,787K
(48.24%↑ Y/Y)
Equity in results of
affiliates
$1,404K
(-39.19%↓ Y/Y)
Net investment gain
(loss)
$937K
(-55.42%↓ Y/Y)
Cost of sales
(exclusive of depreciation...
$660,991K
(10.35%↑ Y/Y)
Selling, research&
development and...
$157,735K
(4.36%↑ Y/Y)
Depreciation and
amortization
$79,641K
(13.93%↑ Y/Y)
Restructuring initiatives
$1,419K
(-10.13%↓ Y/Y)
Net income
$88,010K
(-21.23%↓ Y/Y)
Provision for income taxes
$27,037K
(-3.38%↓ Y/Y)
Interest expense
$16,001K
(47.47%↑ Y/Y)
Miscellaneous expense, net
-$802K
(-568.33%↓ Y/Y)
Net income
attributable to...
$87,573K
(-21.61%↓ Y/Y)
Net income
attributable to redeemable...
$285K
Net (income) loss
attributable to...
$152K
(1166.67%↑ Y/Y)
Back
Back
Income Statement
APTARGROUP, INC. (ATR)
APTARGROUP, INC. (ATR)
source: myfinsight.com